| Description |
1 online resource |
|
text txt rdacontent |
|
computer c rdamedia |
|
online resource cr rdacarrier |
| Series |
Hepatology research and clinical developments
|
| Bibliography |
Includes bibliographical references and index. |
| Note |
Print version record. |
| Contents |
Preface; Chapter 1; Hepatic Hydatidosis; Abstract; I. History of the Disease; II. Description of the Parasite Echinococcus Granulosus; III. Epidemiology of Hydatid Disease; IV. Life Cycle of the Parasite; V. Description of Hydatid Cyst; VI. Clinical Presentation of Hepatic Hydatidosis: Asymptomatic and Symptomatic; VII. Clinical Signs of Hepatic Hydatid Cyst; IX. Sequalae of Hepatic Hydatid Cyst; IX. Differential Diagnosis; X. Investigation of Hepatic Hydatid Disease; Routine and Diagnostic Investigations; Serological Investigation of the Hepatic Hydatidosis |
|
XI. Treatment: Different ModalitiesSteps of the Operation; References; Chapter 2; Natural History of Chronic Hepatitis C Infection: Epidemiology, Outcomes, and Therapeutic Options; Abstract; Epidemiology; Virology/Molecular Biology; Natural History; Hepatitis C Screening; Diagnosis; History and Physical Examination; Laboratory Tests; Imaging; Testing for Fibrosis and Cirrhosis; Treatment; Indications and Considerations; Interferon and Ribavirin; Direct Acting Antiviral; Management; References; Chapter 3; Metabolic Syndrome, Non-Alcoholic Fatty Liver Disease (NAFLD) and Psoriasis; Abstract |
|
1. Introduction2. Metabolic Syndrome; 2.1. Introduction and Definition of Metabolic Syndrome; 2.2. Epidemiology of Metabolic Syndrome; 2.3. Pathophysiology of Metabolic Syndrome; 3. Non-Alcoholic Fatty Liver Disease (NAFLD); 3.1. Introduction and Definition of NAFLD; 3.2. Epidemiology of NAFLD; 3.3. Pathophysiology of NAFLD; 4. Metabolic Syndrome and NAFLD -- The Link; 5. Psoriasis; 5.1. Introduction of Psoriasis; 5.2. Epidemiology of Psoriasis; 5.3. Pathophysiology of Psoriasis; 6. Metabolic Syndrome, NAFLD and Psoriasis -- The Link |
|
7. Treatment of Metabolic Syndrome, NAFLD and Skin Inflammation Co-Morbidity8. Animal Models of NAFLD and Psoriasis; Conclusion; References; Chapter 4; Pathophysiology and Treatment of Liver Cirrhosis; Abstract; Introduction; Pathophysiology of Cirrhosis; Cause of Cirrhosis; Symptom and Laboratory Findings of Cirrhosis; Diagnostic Methods for Liver Cirrhosis; Classification of Liver Function for Patients with Liver Cirrhosis; Prognosis of the Cirrhosis; Hypoalbuminemia in Cirrhosis; Ascites in Cirrhosis; Treatment of Cirrhosis; Administration of Albumin; Branched-Chain Amino Acid (Levact ®) |
|
Albumin SynthesisDiuretics; References; Chapter 5; Surgical Strategies to Push up Resection Limits in Liver Disease and Liver Failure After Surgery; Abstract; Introduction; References; Section 1. Post-Hepatectomy Liver Failure (PHLF); From Transplantation Experience to Oncological Surgery Environment; Epidemiology; Risk Factors; References; Section 2. Classical Approach: The Concept of Size; TLV and FLRV: How to Calculate?; Manual, Semi-Automated and Automated Methods of CTV; References; Rationale and Historical Perspectives of Strategies to Push Up Liver Resection's Limits |
| Subject |
Liver -- Diseases -- Diagnosis.
|
|
Liver -- Diseases -- Treatment.
|
|
Foie -- Maladies -- Diagnostic.
|
|
HEALTH & FITNESS -- Diseases -- General.
|
|
MEDICAL -- Clinical Medicine.
|
|
MEDICAL -- Diseases.
|
|
MEDICAL -- Evidence-Based Medicine.
|
|
MEDICAL -- Internal Medicine.
|
|
Liver -- Diseases -- Treatment
|
|
Liver -- Diseases -- Diagnosis
|
|
Liver -- Diseases
|
| Added Author |
Nelson, Regina, editor.
|
| Other Form: |
Print version: Liver disease. New York : Nova Biomedical, [2016] 9781634856973 (DLC) 2016945131 |
| ISBN |
9781634857192 (ebook) |
|
1634857194 |
|
9781634856973 (hardback) |
| Standard No. |
AU@ 000067595042 |
|
